Surveillance, epidemiology, and end results program

landmark studies.

Publisher: U.S. Dept. of Health and Human Services, National Institutes of Health, National Cancer Institute in [Bethesda, Md.]

Written in English
Published: Pages: 32 Downloads: 593
Share This

Subjects:

  • SEER Program (National Cancer Institute (U.S.)),
  • Cancer -- United States -- Statistics.,
  • Cancer -- Reporting -- United States.,
  • Cancer -- United States -- Mortality.,
  • United States -- Statistics, Medical.

Edition Notes

Other titlesLandmark studies.
GenreStatistics., Statistics, Medical.
SeriesNIH publication -- no. 03-5434.
ContributionsNational Cancer Institute (U.S.)
The Physical Object
FormatMicroform
Pagination[32] p.
Number of Pages32
ID Numbers
Open LibraryOL17722947M

  The National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program of United States population-based data from to offers a unique opportunity to perform detailed analyses of incidence and survival of rare by:   The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute (NCI) is an important source of the longitudinal epidemiological study from multicenter population-based registries, which is updated annually and is available free of charge to the public. 2 days ago  Go to the Webliography source for the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program. In the Fast Stats, create your own cancer statistical report, "Stratified by Data Type," and use all three data types. Examine and bring it back to the class for presentation and interpret your conclusions. Survival of Ventricular and Periventricular High-Grade Gliomas: A Surveillance, Epidemiology, and End Results Program–Based Study Author links open overlay panel Wuyang Yang 1 Tao Xu 2 Tomas Garzon-Muvdi 1 Changchuan Jiang 3 Judy Huang 1 Kaisorn L. Chaichana 1Cited by: 2.

@article{osti_, title = {Management of Male Breast Cancer in the United States: A Surveillance, Epidemiology and End Results Analysis}, author = {Fields, Emma C., E-mail: @ and DeWitt, Peter and Fisher, Christine M. and Rabinovitch, Rachel}, abstractNote = {Purpose: To analyze the stage-specific management of male breast cancer (MBC) . Although conflicting data have been reported on male and female survival outcomes, data from through in the Surveillance, Epidemiology, and End Results (SEER) program have demonstrated that the improvement in breast cancer survival in men has fallen behind that of by: The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program of United States population‐based data from to offers a unique opportunity to perform detailed analyses of incidence and survival of rare by: The Surveillance, Epidemiology and End Results (SEER) database was analyzed for patients diagnosed with Wilms' tumor between and Patients were stratified into pediatric (Cited by:

The Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute (NCI) is a source of epidemiologic information on the incidence and survival rates of . Using data from the Surveillance, Epidemiology, and End Results (SEER) Program for –, we assessed characteristics of the county of residence as predictors of receipt of breast‐conserving surgery and determined whether regional variation persisted . Get this from a library! Surveillance, epidemiology, and end results program: landmark studies.. [National Cancer Institute (U.S.);]. In September , the CSP became the largest registry of the National Cancer Institute-funded Surveillance, Epidemiology, and End Results (SEER) program. The consortium of 18 population-based SEER registries provides the federal government with a “snapshot” of cancer incidence and survival across the United States.

Surveillance, epidemiology, and end results program Download PDF EPUB FB2

The Surveillance, Epidemiology, and End Results (SEER) Program provides information on cancer statistics in an effort to reduce the cancer burden among the U.S.

population. SEER is supported by the Surveillance Research Program (SRP) in NCI's Division of. This mandate led to the establishment of the National Cancer Institute’s (NCI’s) Surveillance, Epidemiology, and End Results (SEER) Program. external icon 1 The SEER Program continues to— Monitor the burden of cancer in the United States.

Provide statistics on cancer incidence, survival, and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) program is an authoritative source of information on cancer incidence and mortality in the United Size: 83KB. SEER (Surveillance, Epidemiology, and End Results Program) Source: Surveillance and Operations Research Branch, Blair Building, RoomNational Cancer Institute (NCI), National Institutes of Health, Bethesda, MDSurveillance, Epidemiology, and End Results (SEER) SEER is supported by the NCI’s Surveillance Research Program (SRP), which provides national leadership in the science of cancer surveillance as well as analytical tools and methodological expertise in File Size: KB.

The Surveillance, Epidemiology, and End Results Program (SEER) tracks the incidence of persons diagnosed with cancer during the year and collects follow-up information on all previously diagnosed patients until their death.

Statistical reports from the Surveillance, Epidemiology, and End And end results program book (SEER) Program are frequently consulted for information on patient survival.

Although informative, these reports generally provide information by stage, age group, and/or calendar year, and the statistic provided is relative survival, which does not account for competing causes of by: 9.

Survival Differences Between Pediatric Head and Neck Versus Body Melanoma in the Surveillance, Epidemiology, and End Results Program. Survival of Ventricular and Periventricular High-Grade Gliomas: A Surveillance, Epidemiology, and End Results Program-Based Study. Yang W(1), Xu T(2), Garzon-Muvdi T(1), Jiang C(3), Huang J(1), Chaichana KL(4).

Author information: (1)Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. From the U.S. Surveillance, Epidemiology, and End Results Program (SEER), the American Cancer Society epidemiology that in94, colon rectum cancer cases will be newly diagnosed, and of these 54% and 44%, respectively, will be diagnosed in women [ 2 ].

56, people will die from CRC, 51% of them women. The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute (NCI) is an authoritative source of information on cancer incidence and survival in the United States.

SEER currently collects and publishes cancer incidence and survival data from population-based cancer registries covering approximately percent of the U.S. population. A retrospective analysis was conducted utilizing the Surveillance, Epidemiology and End Results Program of the National Cancer Institute.

Results Two hundred and thirty-nine patients were identified, with patients receiving by: National Cancer Institute’s (NCI) Surveillance, Epidemiology, and End Results (SEER) Program, and the Commission on Cancer (CoC) of the American College of Surgeons.

The clinicians treating patients with CNS tumors and the researchers studying these tumors felt that it was just as important to study nonmalignant tumors asFile Size: 2MB. Population-based cancer registry data from the Surveillance, Epidemiology, and End Results Program (cases from tofollow-up through ) were used to calculate annual age-adjusted incidence rates of stage IV prostate cancer (overall and for the subset presenting with distant metastases) and to assess time trends in patient, tumor, and treatment characteristics and by:   Surveillance, Epidemiology, and End Results (SEER) Program () SEER*Stat Database: Incidence - SEER 18 Regs Research Data, Nov Sub ().

SEER is supported by the Surveillance Research Program (SRP) in NCI's Division of Cancer Control and Population Sciences (DCCPS).SRP provides national leadership in the science of cancer surveillance as well as analytical tools and methodological expertise in collecting, analyzing, interpreting, and disseminating reliable population-based statistics.

Guidelines, tools, and resources for cancer registrars, including coding and staging manuals, glossary, drug database (SEER*Rx), SEER abstracting tool (SEER*Abs), Q&A resources, and training modules for registration and surveillance. Also read SEER announcements or join e-mail list.

The SEER Program. The Surveillance, Epidemiology and End Results program has been a trusted source for high quality data since It currently monitors cancer incidence and survival in approximately 34% of the U.S.

population. This study compares clinical features and outcomes of SS across the different age groups, by analyzing cases, children/adolescents (≤18 years) and adults, registered in the Surveillance, Epidemiology, and End Results (SEER) 17 database from to Cited by: Options for accessing datasets for incidence, mortality, county populations, standard populations, expected survival, and SEER-linked and specialized data.

Plus variable definitions, documentation for reporting and using datasets, statistical software (SEER*Stat), and observational research resources. NCI's Surveillance, Epidemiology, and End Results (SEER) program provides information on cancer statistics that underpins efforts to reduce the cancer burden among the U.S.

population. Learn more about the SEER program. Additional Physical Format: Online version: SEER, Surveillance, Epidemiology, and End Results Program.

[Bethesda, Md.]: National Institutes of Health, National. The SEER Program is a sequel to two earlier NCI programs, the End Results Program and the Third National Cancer Survey.

Case ascertainment and data collection for the SEER Program began with January 1, diagnoses in several geographic areas of the United States and its by: The Surveillance, Epidemiology, and End Results (SEER) program is an authoritative source of information on cancer incidence and mortality in the United States.

SEER collects and publishes cancer data from a set of 17 population - based regional cancer registries located throughout the country.

Solicitation: 75NDNF Contract: 75ND The purpose of this Task Order is to provide scientific IT project management, project control, and contract administration to enhance SRP’s acquisition of Surveillance, Epidemiology and End Results (SEER) Program pathology and radiology reports.

The contractor provides expertise in discovery and analytic. The authors analyzed changing trends in incidence rates and 5‐year relative survival percentages for patients with anal cancer.

The publicly available data used in the current study were obtained from the Surveillance, Epidemiology, and End Results (SEER) Program, a system of population‐based tumor registries in the United States. RESULTS. The Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute collects data on cancer diagnoses, treatment, and survival for.

The Surveillance, Epidemiology, and End Results (SEER) Program, administered by the National Cancer Institute (NCI), has been funded since as a result of the National Cancer Act of SEER collects reportable cancer cases from 20 U.S.

geographic areas, including 5 states. Most PC studies to date have suffered from small sample sizes. In this retrospective, population-based cohort study, data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program was used to provide a comprehensive descriptive analysis of patients with PC.

The Surveillance, Epidemiology, and End Results Program: A National Resource Benjamin F. Hankey,1 Lynn A. Ries, and Brenda K. Edwards Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland The fight against cancer escalated in with the introductionCited by:.

The training modules on this site are funded by the U.S. National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) Program.

The SEER Training Website is currently undergoing an update and revision cycle. NCI Subject Matter Experts are determining which materials will require updating and have begun that process.THE SURVEILLANCE, EPIDEMIOLOGY, and End Results (SEER) Program of the National Cancer Institute (NCI) is an authoritative source of information on cancer incidence and survival in the United States.

SEER currently collects and publishes cancer.The Surveillance, Epidemiology and End Results (SEER) Program Two National Cancer Institute (NCI) programs, the End Results program and the Third National Cancer Survey, preceded SEER.

The SEER Program was established under the National Cancer Program by the National Cancer Act of ; data collection began in January